I have all the content needed for a comprehensive answer. Let me now compose the full response:
Electron Transport Chain (ETC) & ATP Synthesis
Overview
Energy-rich molecules (glucose, fatty acids, amino acids) are oxidized through metabolic pathways (glycolysis, β-oxidation, TCA cycle) to generate NADH and FADH₂. These reduced coenzymes donate electrons to the ETC, releasing energy that is captured as ATP. This coupling of electron transport to ATP synthesis is called oxidative phosphorylation (OXPHOS).
Diagram 1 — Components of the Respiratory Chain
Components of the electron transport chain showing NADH:CoQ oxidoreductase (Complex I), Succinate dehydrogenase (Complex II), Cytochrome b-c₁ complex (Complex III), and Cytochrome c oxidase (Complex IV). — Basic Medical Biochemistry, 6e
Components of the Respiratory Chain (Complexes I–IV)
| Complex | Name | Prosthetic Groups | Electrons From | Protons Pumped |
|---|
| I | NADH:CoQ oxidoreductase (NADH dehydrogenase) | FMN, Fe-S centers | NADH → CoQ | 4 H⁺ |
| II | Succinate:CoQ oxidoreductase (Succinate dehydrogenase) | FAD, Fe-S centers | FADH₂ → CoQ | 0 H⁺ |
| III | CoQH₂:Cytochrome c oxidoreductase (Cytochrome bc₁) | Cyt b, Fe-S, Cyt c₁ | CoQ → Cyt c | 4 H⁺ |
| IV | Cytochrome c oxidase | Cyt a, Cyt a₃, CuA, CuB | Cyt c → O₂ → H₂O | 2 H⁺ |
| V | ATP synthase (F₁F₀-ATPase) | — | H⁺ gradient → ATP | — |
Mobile carriers (not fixed in complexes):
- Coenzyme Q (CoQ / Ubiquinone): Lipid-soluble; shuttles electrons from Complex I and II (and glycerol-3-phosphate dehydrogenase, acyl-CoA dehydrogenase) to Complex III
- Cytochrome c: Water-soluble; peripheral to the inner mitochondrial membrane; shuttles electrons from Complex III to Complex IV
Diagram 2 — ETC with Proton Pumping & ATP Synthesis
ETC showing proton pumping at Complexes I (4H⁺), III (4H⁺), and IV (2H⁺). Ten H⁺ are pumped per NADH oxidized. Complex V (ATP synthase) uses the gradient to synthesize ATP. — Lippincott Illustrated Reviews: Biochemistry, 8e
ATP Formation — Chemiosmotic Hypothesis (Mitchell Hypothesis)
Mechanism
-
Proton pump: As electrons pass through Complexes I, III, and IV, energy released drives pumping of H⁺ from the matrix to the intermembrane space (IMS).
- 10 H⁺ pumped per NADH oxidized (4+4+2)
- 6 H⁺ pumped per FADH₂ oxidized (0+4+2, entering via CoQ)
-
Electrochemical gradient (Proton-Motive Force): This creates:
- An electrical gradient (positive charge accumulates in IMS)
- A pH gradient (IMS is more acidic than matrix)
- Together = proton-motive force (~220 mV)
-
ATP synthase (Complex V): H⁺ re-enter the matrix through the F₀ channel, driving rotation of the c-ring. This rotational energy is transmitted to the F₁ domain, where conformational changes in the three β subunits cyclically:
- Bind ADP + Pᵢ
- Catalyze phosphorylation (ATP synthesis)
- Release ATP
- One full rotation = 3 ATP; ~3–4 H⁺ needed per ATP
Binding Change Mechanism (Boyer)
The three β subunits exist in three conformational states (open "O", loose "L", tight "T") that rotate with each H⁺ flux. ADP + Pᵢ bind at the open site; ATP is spontaneously synthesized at the tight site; and pre-formed ATP is released as the site becomes open again.
ATP Synthesis Sites
| Site | ATP Yield per Mole |
|---|
| NADH → Complex V (via I, III, IV) | ~2.5 ATP |
| FADH₂ → Complex V (via II, III, IV) | ~1.5 ATP |
| Substrate-level phosphorylation (TCA — succinyl-CoA synthetase) | 1 GTP/ATP |
| Substrate-level phosphorylation (Glycolysis — PGK, PK) | 2 ATP net |
Total ATP from complete glucose oxidation:
- Glycolysis: ~2 ATP (net) + 2 NADH (cytosolic)
- Pyruvate decarboxylation: 2 NADH
- TCA cycle: 6 NADH + 2 FADH₂ + 2 GTP
- Grand total: ~30–32 ATP per glucose
Diagram 3 — Full ETC with ROS Generation
Full ETC showing electron flow, proton pumping, ATP export via VDAC, and superoxide (O₂•⁻) generation at Complexes I and III
Inhibitors of the ETC
A. ETC Electron Transport Inhibitors (Block specific complexes)
| Inhibitor | Site of Action | Mechanism | Clinical/Toxicological Significance |
|---|
| Rotenone | Complex I | Blocks NADH → CoQ electron transfer | Pesticide/insecticide; used in Parkinson's research |
| Amobarbital (Amytal) | Complex I | Blocks FMN/Fe-S region | Barbiturate toxicity |
| TTFA (Thenoyltrifluoroacetone) | Complex II | Blocks Fe-S centers | Experimental inhibitor |
| Antimycin A | Complex III | Blocks Cyt b → Cyt c₁ (inhibits Q cycle) | Fungicide; fish poison |
| BAL (Dimercaprol) | Complex III | Chelates Fe-S centers | Also used as chelation therapy |
| CO (Carbon monoxide) | Complex IV | Binds Cyt a₃, blocks O₂ binding | Lethal poisoning; binds with high affinity |
| Cyanide (CN⁻) | Complex IV | Binds Fe³⁺ of Cyt a₃ | Used in chemical warfare; treated with hydroxocobalamin/thiosulfate |
| Hydrogen sulfide (H₂S) | Complex IV | Similar to CN⁻ | Sewer gas poisoning |
| Azide (N₃⁻) | Complex IV | Binds Cyt a₃ | Laboratory ETC inhibitor |
Effect of ETC inhibitors: Electron flow stops → H⁺ pumping stops → proton-motive force collapses → ATP synthesis stops → NADH and FADH₂ accumulate → O₂ consumption decreases.
B. ATP Synthase (Phosphorylation) Inhibitors
| Inhibitor | Mechanism |
|---|
| Oligomycin | Binds F₀ domain; blocks H⁺ channel → stops proton re-entry → electron transport also stops (respiratory control) |
| Aurovertin | Binds F₁ domain; inhibits ATP synthesis |
| Dicyclohexylcarbodiimide (DCCD) | Reacts covalently with F₀; blocks proton channel |
C. Uncouplers of Oxidative Phosphorylation
Uncouplers dissipate the proton gradient without going through ATP synthase. Electron transport continues (or accelerates), but energy is released as heat instead of ATP.
| Uncoupler | Type | Mechanism |
|---|
| 2,4-Dinitrophenol (DNP) | Synthetic (lipophilic ionophore) | Shuttles H⁺ across inner membrane, bypassing F₀ |
| CCCP (Carbonyl cyanide m-chlorophenylhydrazone) | Synthetic | Protonophore; causes uncoupling |
| Thermogenin / UCP1 | Endogenous (brown fat) | H⁺ channel in inner mitochondrial membrane; non-shivering thermogenesis in neonates; activated by cold via catecholamines |
| UCP2, UCP3 | Endogenous (other tissues) | Role in heat production, regulation of ROS |
| Aspirin (salicylates) — high dose | Drug | Uncouples OXPHOS; mechanism of fever in overdose |
| Long-chain fatty acids | Endogenous | Act as protonophores; can be returned to normal by albumin |
Key feature of uncouplers: O₂ consumption increases (electron transport uninhibited) but ATP synthesis decreases. Body temperature rises (energy released as heat). Weight loss occurs as more fuel is burned without ATP production — the historical basis for DNP's brief use as a diet drug (abandoned due to fatal hyperthermia).
Respiratory Control
In tightly coupled mitochondria, electron transport rate is controlled by ADP availability:
- High ADP → faster electron transport, more O₂ consumption, more ATP synthesis
- Low ADP → electron transport slows (rate-limiting step is H⁺ re-entry through ATP synthase)
- Oligomycin locks mitochondria in a state of low electron transport despite adequate substrate
Summary: Sites of Action
NADH → [Complex I] → CoQ ← [Complex II] ← FADH₂
↓
[Complex III] → Cyt c
↓
[Complex IV] → H₂O
↓
H⁺ gradient (proton-motive force)
↓
[Complex V / ATP Synthase]
↓
ATP
Inhibitors: Uncouplers:
I — Rotenone DNP, Thermogenin (UCP1)
III — Antimycin A Salicylates (high dose)
IV — CN⁻, CO, N₃⁻
V — Oligomycin
Sources:
- Lippincott Illustrated Reviews: Biochemistry, 8th ed. pp. 224–243
- Basic Medical Biochemistry: A Clinical Approach, 6e. pp. 860–878